Clinical trial for Type 1 Diabetes
Official title Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
ClinicalTrials.gov ID: NCT05203640
What this study is testing
- What it's testing
- This study aims to find out how different weight lifting routines change blood sugar levels during and after exercise.
- Who it's for
- The study is looking for post-menopausal women who have type 1 diabetes.
- What's involved
- Participants will perform two different weight lifting programs: one with lighter weights and more repetitions, and one with moderate weights and fewer repetitions.
- Time commitment
- The source text does not specify the total duration or number of visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75, women only
You may be able to join if
- female
- type 1 diabetes diagnosed for at least 1 year
- at least 12 months since last menstrual period
- physically able and willing to perform resistance exercise
- HbA1c \< 10%
You likely can't join if
- Individuals with HbA1c \>9.9%
- Frequent and unpredictable hypoglycaemia
- A change in insulin management strategy within two months of the study
- Blood pressure \> 144/95,
- Severe peripheral neuropathy,
- A history of cardiovascular disease
See the full eligibility criteria
- female
- type 1 diabetes diagnosed for at least 1 year
- at least 12 months since last menstrual period
- physically able and willing to perform resistance exercise
- HbA1c \< 10%
- residing near Edmonton, Alberta / able to attend laboratory based sessions at the University of Alberta
- Individuals with HbA1c \>9.9%
- Frequent and unpredictable hypoglycaemia
- A change in insulin management strategy within two months of the study
- Blood pressure \> 144/95,
- Severe peripheral neuropathy,
- A history of cardiovascular disease
- Musculoskeletal injuries affecting the ability to perform resistance exercise.
- Individuals who are treated with medications (other than insulin) that affect glucose metabolism (e.g. atypical antipsychotics, corticosteroids)
- A body mass index \>30kg/m2,
- Smoking
- Moderate to high alcohol intake (\>2 drinks per day)
The study team makes the final eligibility decision.
Where it is enrolling
- Edmonton, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Edmonton, Alberta, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.